All Effectiveness Bank analyses to date of documents related to alcohol compiled for our partner Alcohol Change UK, starting with the analyses most recently added or updated, totalling today 791 documents.
Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
STUDY 1992 HTM file
Disulfiram treatment of alcoholism
Chick J., Gough K., Falkowski W. et al.
British Journal of Psychiatry: 1992, 161, p. 84–89.
Still relevant today, from the early 1990s a UK randomised trial of disulfiram in the treatment of alcohol dependence found that it significantly reduced drinking when there was daily supervision to make sure patients took the tablets, and they knew these would cause unpleasant physical effects if they drank.
REVIEW 2010 HTM file
Acamprosate for alcohol dependence
Rösner S., Hackl-Herrwerth A., Leucht S. et al.
Cochrane Database of Systematic Reviews: 2010, 9. Art. No. CD004332.
The first review from the prestigious Cochrane collaboration of the drug acamprosate as a treatment for alcohol dependence finds clear evidence that it offers worthwhile if modest benefits in preventing a return to drinking after detoxification.
MATRIX CELL 2020 HTM file
Alcohol Treatment Matrix cell E2: Treatment systems; Generic and cross-cutting issues
Seminal and key studies on local, regional and national systems for effectively and cost-effectively providing treatment. Explores whether payment by results stifles patient-centred practice or stretches services beyond comfort zones, the surprising results of a randomised trial of service-improvement mechanisms, and the multiple answers to how many drinkers should be in treatment. See the remaining four cells in row 2 of the matrix for more on generic features of medical and psychosocial therapies.
HOT TOPIC 2020 HTM file
How many drinkers should be in treatment?
One of our selection of hot topics – important issues which sometimes generate heated debate over the facts or their interpretation. What proportion of England’s problem drinkers might be in treatment, how far does that fall short of the number who should be – and how do we judge ‘should’? The proportion varies to a surprising degree depending on assumptions about who needs treatment.
Key studies on the how the characteristics and functioning of treatment organisations affect implementation and effectiveness. Learn to see organisational context as part of treatment and about two evidence-based US quality improvement resources, and consider what makes treatment services engaging and how they could extend engagement into long-term continuing care. See the remaining four cells in row 2 of the matrix for more on generic features of medical and psychosocial therapies.
Wilson A., McDonald P., Hayes L. et al.
BMJ: 1992, 304, p. 227–230.
‘A minute makes a difference in primary care consultations’, was the finding of a 1992 study about improving the capacity of general practitioners to screen for problems such as heavy drinking, smoking, and high blood pressure. But is extra time on the clock enough to secure routine (as opposed to more frequent) delivery of health promotion and brief intervention?
MATRIX CELL 2019 HTM file
Alcohol Treatment Matrix cell B2: Practitioners; Generic and cross-cutting issues
At the front line the practitioner is to the patient the face of treatment. They can matter enormously – not so much in their formal credentials, but their manner with patients. Tour seminal and key studies which probe the heart of addiction treatment: relationships. See the remaining four cells in row 2 of the matrix for more on generic features of medical and psychosocial therapies.
MATRIX CELL 2020 HTM file
Alcohol Treatment Matrix cell A2: Interventions; Generic and cross-cutting issues
Seminal and key studies on aspects of the treatment of problem drinking relevant both to psychosocial and medical approaches. Focuses on ‘common factors’ often sidelined as components of the ‘placebo effect’, but which are actually active ingredients now recognised as at least as important as the particular therapy. See the remaining four cells in row 2 of the matrix for more on generic features of medical and psychosocial therapies.
MATRIX CELL 2020 HTM file
Alcohol Treatment Matrix cell C2: Management/supervision; Generic and cross-cutting issues
Key studies on management and supervision across psychosocial and medical treatments of problem drinking. Highlights that “Manners Matter”, focuses on staff recruitment, queries the ubiquitous stages of change model, and details the fascinating history of the most controversial issue in alcohol treatment: whether to insist dependent drinkers try for abstinence. See the rest of row 2 of the matrix for more on features common to psychosocial and medical treatments.
Mason T., Sutton M., Whittaker W. et al
Addiction: 2015, 110(7), p. 1120–1128.
A flagship drug treatment policy initiative appears to have backfired in England, where the government’s pilot payment-by-results schemes seem to have led to fewer successful completions of treatment and more prospective patients declining treatment.
Select search results pagePREVIOUS | NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80